xuna
Academic / Other · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study on the Withdrawal of Second-generation Tyrosine Kinase Inhibitors After Dose Reduction in Patients Wit MMR on 12 Month | — | 2022-04-01 |
| Withdrawn | Belimumab for Treatment of cGVHD Following Allo-HCT cGVHD | Phase 1 / Phase 2 | 2022-01-01 |
| Withdrawn | Prophylactic HQP1351 Therapy Post-transplants on Leukemia After Allo-HSCT Prophylactic HQP1351 Therapy, Third Generation TKI | Phase 2 | 2022-01-01 |
| Unknown | A Study for PRO of CML in Real Word CML (Chronic Myelogenous Leukemia) | — | 2021-09-22 |
| Unknown | Outcomes of MF Patients Exposure to Ruxolitinib During Transplantation Time of Hematopoietic Reconstruction | N/A | 2017-04-20 |